BioSpace News Archive

Drug Development

Pfizer and BioNTech Begin Global Phase II/III COVID-19 Vaccine Trial

The vaccine will be dosed at a 30-microgram level with a two-dose regimen. The vaccine is an mRNA product, with the mRNA encoding for the SARS-CoV-2 full length spike glycoprotein (S).

July 28, 2020
·
3 min read
·
Mark Terry
Drug Development

AstraZeneca’s Farxiga Dazzles in Phase III Kidney Disease Trial

AstraZeneca reported successful results from its Phase III DAPA-CKD clinical trial of Farxiga (dapagliflozin) in end stage kidney disease (ESKD).

July 28, 2020
·
2 min read
·
Mark Terry
Biotech Beach

Assessing the Link Between the Microbiome and COVID-19 Requires Multiple Partners

Although COVID-19 primarily presents itself as a respiratory disease, a number of associations have been discovered between the microbiomes and a number of diseases.

July 28, 2020
·
3 min read
·
Alex Keown
Policy

U.S. House of Representatives Sends $3.2 Billion FDA Budget to the Senate

The U.S. House of Representatives approved a $3.2 billion budget proposal for the U.S. Food and Drug Administration (FDA) that will boost the agency’s abilities to approve new medicines and medical devices, as well as protect the nation’s food supplies.

July 28, 2020
·
2 min read
·
Alex Keown
Policy

Federal Government Taps FUJIFILM Texas Site to Manufacture COVID-19 Vaccines

Less than one week after forging a vaccine manufacturing agreement with Novavax, FUJIFILM Diosynth Biotechnologies announced its College Station, Texas facility was selected by the federal government to support COVID-19 vaccine candidate manufacturing.

July 28, 2020
·
2 min read
·
Alex Keown
Business

JLL Report: COVID-19-Related Vaccines Stimulate Life Sciences Real Estate Market

JLL published its JLL 2020 U.S. Life Sciences Outlook, which ranks and tracks the progress of life sciences markets, particularly in how they relate to real estate development.

July 28, 2020
·
5 min read
·
Mark Terry
Genetown

Praxis Precision Medicines Closes $110 Million Series C Financing Round

“We are pleased with and excited by this financing, which supports our continued mission to develop best-in-class therapies that deliver long-term value to human health,” said Marcio Souza, president and chief executive officer of Praxis.

July 28, 2020
·
3 min read
·
Mark Terry
New Study Shows How Aging Can Potentially Impact Lung Regeneration

A study published in the journal Cell Stem Cell today revealed how aging can cause lung regeneration to go awry, which can potentially lead to lung cancer and other diseases.

July 28, 2020
·
3 min read
·
Krystle Vermes
Deals

Sequana Medical Announces €7.3 Million Debt Financing and Provides Clinical Update

Sequana Medical NV, an innovator in the management of fluid overload in liver disease, malignant ascites and heart failure, announces it has secured a €7.3 million debt financing through subordinated loan agreements, of which €1.4 million will be convertible for new shares of the Company.

July 28, 2020
·
8 min read
VALBIOTIS Announces a Cash Position of €10.9M at 30 June 2020

Nearly €8M in Additional Resources Already Secured:

July 28, 2020
·
4 min read